Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.

Deguchi S, Yamashita T, Igai K, Harada K, Toba Y, Hirata K, Takayama K, Mizuguchi H.

Drug Metab Dispos. 2019 Jun;47(6):632-638. doi: 10.1124/dmd.119.086322. Epub 2019 Apr 8.

PMID:
30962288
2.

FGF signal is not required for hepatoblast differentiation of human iPS cells.

Toba Y, Kiso A, Nakamae S, Sakurai F, Takayama K, Mizuguchi H.

Sci Rep. 2019 Mar 6;9(1):3713. doi: 10.1038/s41598-019-40305-2.

3.

Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research.

Takayama K, Hagihara Y, Toba Y, Sekiguchi K, Sakurai F, Mizuguchi H.

Biomaterials. 2018 Apr;161:24-32. doi: 10.1016/j.biomaterials.2018.01.019. Epub 2018 Jan 18.

PMID:
29421559
4.

Nanaomycin A Treatment Promotes Hepatoblast Differentiation from Human iPS Cells.

Nakamae S, Toba Y, Takayama K, Sakurai F, Mizuguchi H.

Stem Cells Dev. 2018 Mar 15;27(6):405-414. doi: 10.1089/scd.2017.0251. Epub 2018 Feb 27.

PMID:
29378471
5.

Clinical characteristics of ruptured distal middle cerebral artery aneurysms: Review of the literature.

Tsutsumi K, Horiuchi T, Nagm A, Toba Y, Hongo K.

J Clin Neurosci. 2017 Jun;40:14-17. doi: 10.1016/j.jocn.2016.12.019. Epub 2017 Jan 10. Review.

PMID:
28087184
6.
7.

Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.

Machida S, Toba Y, Nishimura T, Ohzeki T, Murai K, Kurosaka D.

Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1423-33. doi: 10.1007/s00417-014-2594-6. Epub 2014 Mar 2.

PMID:
24584708
8.

Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase I interaction.

Manita D, Toba Y, Takakusagi Y, Matsumoto Y, Kusayanagi T, Takakusagi K, Tsukuda S, Takada K, Kanai Y, Kamisuki S, Sakaguchi K, Sugawara F.

Bioorg Med Chem. 2011 Dec 15;19(24):7690-7. doi: 10.1016/j.bmc.2011.09.059. Epub 2011 Oct 5.

PMID:
22071521
9.

Investigation and characterization of rat bipedal walking models established by a training program.

Wada N, Toba Y, Iwamoto W, Goto M, Miyata H, Mori F, Morita F.

Brain Res. 2008 Dec 3;1243:70-7. doi: 10.1016/j.brainres.2008.09.034. Epub 2008 Sep 20.

PMID:
18835381
10.

Photopic negative response of focal electoretinograms in glaucomatous eyes.

Machida S, Toba Y, Ohtaki A, Gotoh Y, Kaneko M, Kurosaka D.

Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5636-44. doi: 10.1167/iovs.08-1946. Epub 2008 Jul 18.

PMID:
18641287
11.

Correlation between photopic negative response and retinal nerve fiber layer thickness and optic disc topography in glaucomatous eyes.

Machida S, Gotoh Y, Toba Y, Ohtaki A, Kaneko M, Kurosaka D.

Invest Ophthalmol Vis Sci. 2008 May;49(5):2201-7. doi: 10.1167/iovs.07-0887.

PMID:
18436853
12.

CXCR4/SDF-1 system modulates development of GnRH-1 neurons and the olfactory system.

Toba Y, Tiong JD, Ma Q, Wray S.

Dev Neurobiol. 2008 Mar;68(4):487-503. doi: 10.1002/dneu.20594.

13.

The effect of milk basic protein supplementation on bone metabolism during training of young thoroughbred racehorses.

Inoue Y, Asai Y, Tomita M, Kuribara K, Kobayashi M, Kaneko M, Toba Y.

Equine Vet J Suppl. 2006 Aug;(36):654-8.

PMID:
17402500
14.

Milk basic protein increases alveolar bone formation in rat experimental periodontitis.

Seto H, Toba Y, Takada Y, Kawakami H, Ohba H, Hama H, Horibe M, Nagata T.

J Periodontal Res. 2007 Feb;42(1):85-9.

PMID:
17214644
15.

Milk basic protein increases bone mineral density and improves bone metabolism in healthy young women.

Uenishi K, Ishida H, Toba Y, Aoe S, Itabashi A, Takada Y.

Osteoporos Int. 2007 Mar;18(3):385-90. Epub 2006 Oct 18.

PMID:
17048062
17.

[Long-term suppressive effect of falecalcitriol on parathyroid hormone secretion in secondary hyperparathyroidism in hemodialysis patients].

Iwao Y, Yamaguchi Y, Fujii K, Toba Y, Asada M, Nagano N, Yamamoto H, Hyoma K, Yamada S, Hirano H, Tone Y, Ohtani H, Saika Y, Fujii R.

Clin Calcium. 2006 May;16(5):847-51. Japanese.

PMID:
16679628
18.

A controlled trial of the effect of milk basic protein (MBP) supplementation on bone metabolism in healthy menopausal women.

Aoe S, Koyama T, Toba Y, Itabashi A, Takada Y.

Osteoporos Int. 2005 Dec;16(12):2123-8. Epub 2005 Aug 31.

PMID:
16133638
19.

Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse.

Toba Y, Pakiam JG, Wray S.

Eur J Neurosci. 2005 Jul;22(1):79-92.

PMID:
16029198
20.

Phosphorylation of starch and dextrin by dry-heating in the presence of phosphate, and their calcium phosphate-solubilizing ability.

Nakano T, Salvador AS, Tamochi J, Sugimoto Y, Ibrahim HR, Toba Y, Aoe S, Kawakami H, Aoki T.

Nahrung. 2003 Aug;47(4):274-8.

PMID:
13678269
21.

A novel type of milk calcium has higher calcium bioavailability compared with the hydroxyapatite type of milk calcium.

Kato K, Toba Y, Matsuyama H, Aoki T, Aoe S, Takada Y.

J Nutr Sci Vitaminol (Tokyo). 2002 Oct;48(5):390-4.

PMID:
12656213
22.

Cystatin C in milk basic protein (MBP) and its inhibitory effect on bone resorption in vitro.

Matsuoka Y, Serizawa A, Yoshioka T, Yamamura J, Morita Y, Kawakami H, Toba Y, Takada Y, Kumegawa M.

Biosci Biotechnol Biochem. 2002 Dec;66(12):2531-6.

23.

Milk calcium taken with cheese increases bone mineral density and bone strength in growing rats.

Kato K, Takada Y, Matsuyama H, Kawasaki Y, Aoe S, Yano H, Toba Y.

Biosci Biotechnol Biochem. 2002 Nov;66(11):2342-6.

24.

Expression and immunohistochemical localization of heparan sulphate proteoglycan N-syndecan in the migratory pathway from the rat olfactory placode.

Toba Y, Horie M, Sango K, Tokashiki A, Matsui F, Oohira A, Kawano H.

Eur J Neurosci. 2002 May;15(9):1461-73.

PMID:
12028356
25.

Milk basic protein (MBP) increases radial bone mineral density in healthy adult women.

Yamamura J, Aoe S, Toba Y, Motouri M, Kawakami H, Kumegawa M, Itabashi A, Takada Y.

Biosci Biotechnol Biochem. 2002 Mar;66(3):702-4.

26.

Immunohistochemical localization of calbindin D-28k in the migratory pathway from the rat olfactory placode.

Toba Y, Ajiki K, Horie M, Sango K, Kawano H.

J Neuroendocrinol. 2001 Aug;13(8):683-94.

PMID:
11489085
27.

Milk basic protein promotes bone formation and suppresses bone resorption in healthy adult men.

Toba Y, Takada Y, Matsuoka Y, Morita Y, Motouri M, Hirai T, Suguri T, Aoe S, Kawakami H, Kumegawa M, Takeuchi A, Itabashi A.

Biosci Biotechnol Biochem. 2001 Jun;65(6):1353-7.

28.

Changes of activity inducing chromosomal aberrations and transformations of chlorinated humic acid.

Itoh S, Ikeda D, Toba Y, Sumitomo H.

Water Res. 2001 Aug;35(11):2621-8.

PMID:
11456160
29.

Controlled trial of the effects of milk basic protein (MBP) supplementation on bone metabolism in healthy adult women.

Aoe S, Toba Y, Yamamura J, Kawakami H, Yahiro M, Kumegawa M, Itabashi A, Takada Y.

Biosci Biotechnol Biochem. 2001 Apr;65(4):913-8.

30.

Milk basic protein: a novel protective function of milk against osteoporosis.

Toba Y, Takada Y, Yamamura J, Tanaka M, Matsuoka Y, Kawakami H, Itabashi A, Aoe S, Kumegawa M.

Bone. 2000 Sep;27(3):403-8.

PMID:
10962352
31.

Preparation and characterization of milk calcium salts by using casein phosphopeptide.

Nakano T, Sugimoto Y, Ibrahim HR, Toba Y, Aoe S, Aoki T.

Prep Biochem Biotechnol. 2000 May;30(2):155-66.

PMID:
10794185
32.

Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats.

Toba Y, Kajita Y, Masuyama R, Takada Y, Suzuki K, Aoe S.

J Nutr. 2000 Feb;130(2):216-20.

PMID:
10720172
33.

Anchoring method for hemifacial spasm associated with vertebral artery: technical note.

Kyoshima K, Watanabe A, Toba Y, Nitta J, Muraoka S, Kobayashi S.

Neurosurgery. 1999 Dec;45(6):1487-91.

PMID:
10598720
34.

Bioavailability of milk micellar calcium phosphate-phosphopeptide complex in rats.

Toba Y, Kato K, Takada Y, Tanaka M, Nakano T, Aoki T, Aoe S.

J Nutr Sci Vitaminol (Tokyo). 1999 Jun;45(3):311-23.

PMID:
10524350
35.

Preparation and characterization of micellar calcium phosphate-casein phosphopeptide complex.

Aoki T, Nakano T, Iwashita T, Sugimoto Y, Ibraham HR, Toba Y, Aoe S, Nakajima I.

J Nutr Sci Vitaminol (Tokyo). 1998 Jun;44(3):447-56.

PMID:
9742464
36.

Multiple isoforms of neuregulin are expressed in developing rat dorsal root ganglia.

Shinoda J, Nakao J, Iizuka Y, Toba Y, Yazaki T, Kawase T, Uyemura K.

J Neurosci Res. 1997 Dec 1;50(5):673-83.

PMID:
9418956
37.

Role of Arg112 of cytochrome p450cam in the electron transfer from reduced putidaredoxin. Analyses with site-directed mutants.

Unno M, Shimada H, Toba Y, Makino R, Ishimura Y.

J Biol Chem. 1996 Jul 26;271(30):17869-74.

38.

Suprachiasmal carotid-ophthalmic artery aneurysm--report of two cases.

Diraz A, Kobayashi S, Okudera H, Nakagawa F, Tsuji T, Toba Y.

Neurol Med Chir (Tokyo). 1992 Dec;32(13):952-6.

39.

General pharmacological properties of the new vasodilator flosequinan.

Ikezono K, Fujita S, Umezato M, Hosoki E, Toba Y, Kusunoki A, Shintani S.

Arzneimittelforschung. 1992 Oct;42(10):1200-11.

PMID:
1472141
40.

General pharmacological properties of the main metabolite of flosequinan.

Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S.

Arzneimittelforschung. 1992 Oct;42(10):1212-22.

PMID:
1335257
41.

Charged particle decay from giant monopole resonance in 28Si.

Toba Y, Lui Y, Youngblood DH, Garg U, Grabmayr P, Knöpfle KT, Riedesel H, Wagner GJ.

Phys Rev C Nucl Phys. 1990 Apr;41(4):1417-1434. No abstract available.

PMID:
9966490
42.

Bilateral subdural empyema due to Salmonella enteritidis in an infant.

Okudera H, Toba Y, Kyoshima K.

Childs Nerv Syst. 1989 Feb;5(1):45-6.

PMID:
2564810
43.

[Monostotic fibrous dysplasia of the sphenoidal bone presenting with visual disturbance during pregnancy].

Okudera H, Toba Y, Kyoshima K, Kobayashi S.

No To Shinkei. 1988 Aug;40(8):727-32. Japanese.

PMID:
3179086
44.

[Fenestration of the middle cerebral artery associated with cerebral infarction. Report of two cases].

Okudera H, Koike J, Toba Y, Kuroyanagi T, Kyoshima K, Kobayashi S.

Neurol Med Chir (Tokyo). 1987 Jun;27(6):559-63. Review. Japanese. No abstract available.

45.

Giant quadrupole and monopole resonances in 28Si.

Lui Y, Bronson JD, Youngblood DH, Toba Y, Garg U.

Phys Rev C Nucl Phys. 1985 May;31(5):1643-1650. No abstract available.

PMID:
9952700
46.

General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.

Shintani S, Toba Y, Suzuki S, Ninomiya S, Umezato M, Hiyama T.

Arzneimittelforschung. 1985;35(7A):1157-62.

PMID:
4074429
47.

General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.

Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S, et al.

Arzneimittelforschung. 1985;35(7A):1163-72.

PMID:
3000392
48.
49.

Craniopharyngioma--analysis of surgical procedure.

Takahashi T, Fujii H, Toba Y, Isayama Y, Tamaki N, Matsumoto S.

Jpn J Ophthalmol. 1983;27(2):380-6.

PMID:
6620721
50.

[Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)].

Shintani S, Umezato M, Toba Y, Yamaji Y, Kitaura K, Tani T, Ishiyama H, Kikuchi T, Mori T, Nakai S, Watanabe K, Hiyama T.

Nihon Yakurigaku Zasshi. 1982 Mar;79(3):173-91. Japanese.

PMID:
6123475

Supplemental Content

Support Center